Screener
Healthpeak Properties DOC Payments to Noncontrolling Interests
Payments to Noncontrolling Interests at other companies
Other financials
Where this comes from
Reported directly by Healthpeak Properties in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToMinorityShareholders.
The source filing: Healthpeak Properties’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:16 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031287
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Issuance of common stock, net of offering costs | 97 | 64 |
| Repurchase of common stock | (1,374) | (24,959) |
| Dividends paid on common stock | (211,994) | (213,479) |
| Distributions to and redemption of noncontrolling interests | (141,749) | (10,200) |
| Proceeds from Janus Living initial public offering, net of underwriting fees | 901,326 | — |
| Noncontrolling interest issuance costs | (6,963) | — |
| Net cash provided by (used in) financing activities | 1,105,933 | (94,414) |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 728,207 | (45,699) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Healthpeak Properties's payments to noncontrolling interests?
- Healthpeak Properties (DOC) reported payments to noncontrolling interests of $141.75M in Q1 2026.
- How has Healthpeak Properties's payments to noncontrolling interests changed year-over-year?
- Healthpeak Properties's payments to noncontrolling interests increased by 1289.7% year-over-year, from $10.2M to $141.75M.
- What is the long-term trend for Healthpeak Properties's payments to noncontrolling interests?
- Over 4 years (2021 to 2025), Healthpeak Properties's payments to noncontrolling interests has grown at a -20.2% compound annual growth rate (CAGR), from $93.31M to $37.87M.
Ask your AI about Healthpeak Properties's payments to noncontrolling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude